Jason Weisstein
Adult Reconstructive Orthopaedic Surgery · Stuart, FLNPI 1003817693
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 60.4% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2020 at $9,351 and has fallen 92.8% since, to $677 in 2025.
Across 87 payments — averaging $249.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$13K
- Stryker$4K
- Zimmer Biomet$2K
- Medtronic$1K
- BD$433
- Biofire Diagnostics, LLC$425
- plus $674 from 5 others
What the payments were for
- Consulting fees$3,25315%
- Speaking & faculty fees$11,23252%
- Travel & lodging$3,64017%
- Food & beverage$3,12114%
- Education$4632%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 25 | $13,118 |
| Stryker | 39 | $3,797 |
| Zimmer Biomet | 14 | $1,942 |
| Medtronic | 1 | $1,320 |
| BD | 1 | $433 |
| Biofire Diagnostics, LLC | 1 | $425 |
| Pacira Pharmaceuticals Incorporated | 1 | $307 |
| Southern Edge Orthopaedics, Inc. | 1 | $134 |
| Medacta USA, Inc. | 1 | $121 |
| Johnson & Johnson(2 entities) | 2 | $97 |
| KCI USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Anthology$4,633
- ACCORD$4,629
- Journey II BCS$4,611
- BIRMINGHAM HIP$4,000
- Journey II$4,000
- Journey II CR$4,000
- REDAPT$2,000
- MAKO$1,565
- ACCOLADE$1,500
- TRIATHLON$1,500
- ROSA$1,033
- POLARSTEM$633
- BioFire FilmArray$425
- Persona$379
- VISIONAIRE Cutting Guides$363
- EXPAREL$307
- R3$296
- Navio Surgical System$267
- REDAPT Revision Hip System$267
- Legion Revision$267
How this compares
$21,710 in reported general payments places this provider in the 60th percentile of 96 adult reconstructive orthopaedic surgery providers in Florida.
See all adult reconstructive orthopaedic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 25 | $664 |
| Tramadol Hcl | 59 | $146 |
| Oxycodone Hcl | 37 | $140 |
| Meloxicam | 52 | $102 |
| Methylprednisolone | 11 | $72 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Stuart
- Carlos LaverniaMiami$5.4M
- Juan SuarezMiami$3.9M
- John RedmondJacksonville$987K
- Gavan DuffyJacksonville$543K
- Timothy van de LeurSummerfield$511K
- Edward StolarskiSarasota$445K
- Andrew NoblePalm Beach Gardens$308K
- Raul GostheMiami$252K
- Chancellor GrayGainesville$228K
- David BacksteinNaples$199K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.